Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-09

Clinical Trial Update: Impact of Mulberry Leaf on Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2 and Phase 3 trials evaluating mulberry leaf extract for Type 2 diabetes; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mulberry leaf extract (Morus alba leaf extract)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-08-09